This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Couette, B. Articles by Rafestin-Oblin, M.-E. Search for Related Content PubMed PubMed Citation Articles by Couette, B. Articles by Rafestin-Oblin, M.-E.

Folding Requirements of the Ligand-Binding Domain of the Human Mineralocorticoid Receptor

INSERM U478 (B.C., C.H-L., J.F., M-E.R-O.) Faculté de Médecine Xavier Bichat Institut Fédératif de Recherche 02 BP 416, 75870 Paris Cédex 18, France
INSERM U300 (S.J., B.L., G.A.) Faculté de Pharmacie 34060 Montpellier, France

The effects of aldosterone are mediated by the mineralocorticoid receptor (MR), a ligand-dependent transcription factor. We investigated the structural determinants for ligand binding to the receptor using a series of human MR (hMR) deletion mutants. These proteins were produced in vitro in rabbit reticulocyte lysate and analyzed for their ability to bind agonists, antagonists, and the heat shock protein hsp90, which is a prerequisite for ligand binding to hMR. Studies on N terminus-truncated hMRs showed that the ligand-binding domain (LBD: amino acids 734–984) has a lower affinity for aldosterone than the entire receptor [dissociation constant (K_d) 2.9 vs. 0.47 nM] and does not interact with hsp90. Addition of the five- amino acid sequence (729–733) upstream from the LBD is necessary for interaction with hsp90, but a larger region is needed for high aldosterone affinity. Deletions at the C-terminal end of the hMR greatly reduced both agonist and antagonist binding: deletion of the last three amino acids reduced the affinity for aldosterone to 1/20 that of the entire protein, and deletion of the last four amino acids completely abolished binding, although the interaction with hsp90 was not affected. These effects can be explained by misfolding of the receptor, since limited proteolysis assays showed that deletions at the C-terminal end of hMR affect the accessibility of the cleavage sites within the DNA-binding domain and the N-terminal part of the hinge region to trypsin. Thus, our results support the idea that a short sequence upstream of the LBD is essential for the interaction of hMR with hsp90 and that the C terminus of hMR and hsp90 are both essential for folding of the receptor in a high-affinity hormone-binding state.

This article has been cited by other articles:

				A.-N. Takeda, G. M. Pinon, M. Bens, J. Fagart, M.-E. Rafestin-Oblin, and A. Vandewalle The Synthetic Androgen Methyltrienolone (R1881) Acts as a Potent Antagonist of the Mineralocorticoid Receptor Mol. Pharmacol., February 1, 2007; 71(2): 473 - 482. [Abstract] [Full Text] [PDF]

				F. G. Riepe, J. Finkeldei, L. de Sanctis, S. Einaudi, A. Testa, B. Karges, M. Peter, M. Viemann, J. Grotzinger, W. G. Sippell, et al. Elucidating the Underlying Molecular Pathogenesis of NR3C2 Mutants Causing Autosomal Dominant Pseudohypoaldosteronism Type 1 J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4552 - 4561. [Abstract] [Full Text] [PDF]

				F. L. Fernandes-Rosa, M. de Castro, A. C. Latronico, W. G. Sippell, F. G. Riepe, and S. R. Antonini Recurrence of the R947X Mutation in Unrelated Families with Autosomal Dominant Pseudohypoaldosteronism Type 1: Evidence for a Mutational Hot Spot in the Mineralocorticoid Receptor Gene J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3671 - 3675. [Abstract] [Full Text] [PDF]

				C. W. Bolten and M. I. Heron Early cardiac mineralocorticoid receptor-regulated genes: identifying the not so usual suspects. Endocrinology, July 1, 2006; 147(7): 3181 - 3182. [Full Text] [PDF]

				J. Fagart, C. Seguin, G. M. Pinon, and M.-E. Rafestin-Oblin The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor Mol. Pharmacol., May 1, 2005; 67(5): 1714 - 1722. [Abstract] [Full Text] [PDF]

				A. D. Petrescu, R. Hertz, J. Bar-Tana, F. Schroeder, and A. B. Kier Role of Regulatory F-domain in Hepatocyte Nuclear Factor-4{alpha} Ligand Specificity J. Biol. Chem., April 29, 2005; 280(17): 16714 - 16727. [Abstract] [Full Text] [PDF]

				T. Prince and R. L. Matts Definition of Protein Kinase Sequence Motifs That Trigger High Affinity Binding of Hsp90 and Cdc37 J. Biol. Chem., September 17, 2004; 279(38): 39975 - 39981. [Abstract] [Full Text] [PDF]

				P. Sartorato, F. Cluzeaud, J. Fagart, S. Viengchareun, M. Lombes, and M.-C. Zennaro New Naturally Occurring Missense Mutations of the Human Mineralocorticoid Receptor Disclose Important Residues Involved in Dynamic Interactions with Deoxyribonucleic Acid, Intracellular Trafficking, and Ligand Binding Mol. Endocrinol., September 1, 2004; 18(9): 2151 - 2165. [Abstract] [Full Text] [PDF]

				F. G. Riepe, N. Krone, M. Morlot, M. Peter, W. G. Sippell, and C.-J. Partsch Autosomal-Dominant Pseudohypoaldosteronism Type 1 in a Turkish Family Is Associated with a Novel Nonsense Mutation in the Human Mineralocorticoid Receptor Gene J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2150 - 2152. [Abstract] [Full Text] [PDF]

				P. Sartorato, A.-L. Lapeyraque, D. Armanini, U. Kuhnle, Y. Khaldi, R. Salomon, V. Abadie, E. Di Battista, A. Naselli, A. Racine, et al. Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2508 - 2517. [Abstract] [Full Text] [PDF]

				M. Nishi, H. Ogawa, T. Ito, K.-I. Matsuda, and M. Kawata Dynamic Changes in Subcellular Localization of Mineralocorticoid Receptor in Living Cells: In Comparison with Glucocorticoid Receptor using Dual-Color Labeling with Green Fluorescent Protein Spectral Variants Mol. Endocrinol., July 1, 2001; 15(7): 1077 - 1092. [Abstract] [Full Text] [PDF]

				C. Hellal-Levy, J. Fagart, A. Souque, J.-M. Wurtz, D. Moras, and M.-E. Rafestin-Oblin Crucial Role of the H11-H12 Loop in Stabilizing the Active Conformation of the Human Mineralocorticoid Receptor Mol. Endocrinol., August 1, 2000; 14(8): 1210 - 1221. [Abstract] [Full Text]

				D. Le Menuet, S. Viengchareun, P. Penfornis, F. Walker, M.-C. Zennaro, and M. Lombes Targeted Oncogenesis Reveals a Distinct Tissue-specific Utilization of Alternative Promoters of the Human Mineralocorticoid Receptor Gene in Transgenic Mice J. Biol. Chem., March 10, 2000; 275(11): 7878 - 7886. [Abstract] [Full Text] [PDF]